Melanoma (BRAF V600, unresectable, metastatic) - dabrafenib [ID605]: final appraisal determination document
Melanoma (BRAF V600, unresectable, metastatic) - dabrafenib [ID605]: final appraisal determination document
18 September 2014 (335.48 Kb 37 sec) |
This page was last updated: 17 September 2014